H B Barner1, T M Sundt, M Bailey, Y Zang. 1. Division of Cardiothoracic Surgery, Washington University School of Medicine, St. Louis, MO 63110, USA. barnerh@msnotes.wustl.edu
Abstract
OBJECTIVE: To report the authors' 7-year experience with the internal thoracic artery/radial artery (ITA/RA) T graft as the only conduits for myocardial revascularization in two- and three-vessel disease. SUMMARY BACKGROUND DATA: One and two arterial conduits provide increasing survival benefit for coronary grafting and reduce the need for reintervention. Exclusive use of arterial conduits may provide further benefit. METHODS: From October 1993 to November 2000, 1,020 patients underwent complete arterial revascularization with the ITA/RA T graft. The authors focus on the 909 having initial bypass, with a mean age of 60 and 20% age 70 or older. The incidence of triple-vessel disease was 73%, female gender 28%, diabetes mellitus 27%, peripheral vascular disease 11%, cerebrovascular disease 10%, and chronic obstructive pulmonary disease 6%; ejection fraction was less than 35% in 11%. Perioperative data were collected prospectively. Follow-up information was obtained at a mean of 35.4 months (range 1-88) and was 95% complete. RESULTS: There were seven (0.08%) deaths within 30 days of surgery. The incidence of perioperative infarction was 3.3%, low cardiac output 2.7%, stroke 2.2%, reoperation for bleeding 3.8%, and deep sternal infection 0.8%. The actuarial survival rate was 90% at 5 years, freedom from infarction was 94%, freedom from catheterization was 83%, and freedom from reintervention (angioplasty or reoperation) was 93%. CONCLUSION: The ITA/RA T graft for complete arterial revascularization is associated with a low rate of perioperative death and complications and 5-year survival and freedom from reintervention values consistent with other revascularization strategies.
OBJECTIVE: To report the authors' 7-year experience with the internal thoracic artery/radial artery (ITA/RA) T graft as the only conduits for myocardial revascularization in two- and three-vessel disease. SUMMARY BACKGROUND DATA: One and two arterial conduits provide increasing survival benefit for coronary grafting and reduce the need for reintervention. Exclusive use of arterial conduits may provide further benefit. METHODS: From October 1993 to November 2000, 1,020 patients underwent complete arterial revascularization with the ITA/RA T graft. The authors focus on the 909 having initial bypass, with a mean age of 60 and 20% age 70 or older. The incidence of triple-vessel disease was 73%, female gender 28%, diabetes mellitus 27%, peripheral vascular disease 11%, cerebrovascular disease 10%, and chronic obstructive pulmonary disease 6%; ejection fraction was less than 35% in 11%. Perioperative data were collected prospectively. Follow-up information was obtained at a mean of 35.4 months (range 1-88) and was 95% complete. RESULTS: There were seven (0.08%) deaths within 30 days of surgery. The incidence of perioperative infarction was 3.3%, low cardiac output 2.7%, stroke 2.2%, reoperation for bleeding 3.8%, and deep sternal infection 0.8%. The actuarial survival rate was 90% at 5 years, freedom from infarction was 94%, freedom from catheterization was 83%, and freedom from reintervention (angioplasty or reoperation) was 93%. CONCLUSION: The ITA/RA T graft for complete arterial revascularization is associated with a low rate of perioperative death and complications and 5-year survival and freedom from reintervention values consistent with other revascularization strategies.
Authors: B W Lytle; E H Blackstone; F D Loop; P L Houghtaling; J H Arnold; R Akhrass; P M McCarthy; D M Cosgrove Journal: J Thorac Cardiovasc Surg Date: 1999-05 Impact factor: 5.209
Authors: G Possati; M Gaudino; F Alessandrini; N Luciani; F Glieca; C Trani; C Cellini; C Canosa; G Di Sciascio Journal: J Thorac Cardiovasc Surg Date: 1998-12 Impact factor: 5.209
Authors: C Acar; A Ramsheyi; J Y Pagny; V Jebara; P Barrier; J N Fabiani; A Deloche; J L Guermonprez; A Carpentier Journal: J Thorac Cardiovasc Surg Date: 1998-12 Impact factor: 5.209
Authors: O Wendler; B Hennen; T Markwirth; J König; D Tscholl; Q Huang; E Shahangi; H J Schäfers Journal: J Thorac Cardiovasc Surg Date: 1999-11 Impact factor: 5.209
Authors: I A Apostolidou; G J Despotis; C W Hogue; N J Skubas; C A McCawley; E L Hauptmann; D G Lappas Journal: Ann Thorac Surg Date: 1999-02 Impact factor: 4.330